Oncotarget

Research Papers:

Insights into the role and regulation of TCTP in skeletal muscle

Craig A. Goodman _, Allison M. Coenen, John W. Frey, Jae-Sung You, Robert G. Barker, Barnaby P. Frankish, Robyn M. Murphy and Troy A. Hornberger

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:18754-18772. https://doi.org/10.18632/oncotarget.13009

Metrics: PDF 1879 views  |   HTML 3793 views  |   ?  


Abstract

Craig A. Goodman1,2,3, Allison M. Coenen1, John W. Frey1, Jae-Sung You1, Robert G. Barker4, Barnaby P. Frankish4, Robyn M. Murphy4, Troy A. Hornberger1

1Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, 53706, USA

2Centre for Chronic Disease Prevention and Management, College of Health and Biomedicine, Victoria University, Melbourne, Victoria, 8001, Australia

3Institute for Sport, Exercise and Active Living (ISEAL), Victoria University, Melbourne, Victoria, 8001, Australia

4Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, 3086, Australia

Correspondence to:

Craig A. Goodman, email: [email protected]

Keywords: muscle hypertrophy, muscle atrophy, cancer, duchenne muscular dystrophy, proteostasis

Received: June 16, 2016     Accepted: September 28, 2016     Published: November 01, 2016

ABSTRACT

The translationally controlled tumor protein (TCTP) is upregulated in a range of cancer cell types, in part, by the activation of the mechanistic target of rapamycin (mTOR). Recently, TCTP has also been proposed to act as an indirect activator of mTOR. While it is known that mTOR plays a major role in the regulation of skeletal muscle mass, very little is known about the role and regulation of TCTP in this post-mitotic tissue. This study shows that muscle TCTP and mTOR signaling are upregulated in a range of mouse models (mdx mouse, mechanical load-induced hypertrophy, and denervation- and immobilization-induced atrophy). Furthermore, the increase in TCTP observed in the hypertrophic and atrophic conditions occurred, in part, via a rapamycin-sensitive mTOR-dependent mechanism. However, the overexpression of TCTP was not sufficient to activate mTOR signaling (or increase protein synthesis) and is thus unlikely to take part in a recently proposed positive feedback loop with mTOR. Nonetheless, TCTP overexpression was sufficient to induce muscle fiber hypertrophy. Finally, TCTP overexpression inhibited the promoter activity of the muscle-specific ubiquitin proteasome E3-ligase, MuRF1, suggesting that TCTP may play a role in inhibiting protein degradation. These findings provide novel data on the role and regulation of TCTP in skeletal muscle in vivo.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 13009